Completed
SAD/MAD Study of a New Formulation of Nebulised RPL554 in Healthy Subjects and COPD Subjects
NCT02307162
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disorder, Disease Attributes, +7 more
- Locations
-
- Medicines Evaluation Unit Manchester, United Kingdom